Fundraising Fox
Annexon
So. San Francisco, US · Founded 2011 · 114 employees on LinkedIn · 15 known investors
Find your way into Annexon
Sign up to see every warm intro you have to Annexon
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Annexon team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Annexon is a clinical-stage biopharmaceutical company developing C1q and classical complement pathway inhibitors to treat complement-mediated autoimmune, neurodegenerative, and ophthalmic disorders. Its pipeline targets diseases of the body, brain, and eye, including Guillain-Barré syndrome and geographic atrophy.
Founders & leadership
Annexon was founded in 2011 by Ben Barres and Douglas Love.
Board
Investors · 15
How we know: Bain Capital Life Sciences's portfolio page · biospace.com · Not right? Tell us
How we know: Correlation Ventures's portfolio page · Not right? Tell us
How we know: biospace.com · Not right? Tell us
How we know: funding news · biospace.com · Not right? Tell us
How we know: biospace.com · Not right? Tell us
How we know: funding news · biospace.com · Not right? Tell us
How we know: funding news · biospace.com · Not right? Tell us
How we know: funding news · biospace.com · Not right? Tell us
Also in the syndicate · 6
Reported raises · per SEC filings
Form D private placements$277.5M disclosed across 3 of 5 rounds · 2018–2025
▶$130.5MraisedJul 2022 · 12 investors · BiotechnologyRule 506(b)
- William D. WaddillDirector
- Thomas G. WiggansDirector
- Muneer A. SatterDirector
- Michael OverdorfExecutive Officer
- Larry C. Mattheakis, Ph.DExecutive Officer
- Douglas LoveExecutive Officer, Director
- Jennifer LewExecutive Officer
- Bettina M. Cockroft, M.D.Director
- William H. Carson, M.D.Director
- Jung E. ChoiDirector
- Offering amount
- $130.5M
- Amount sold
- $130.5M
- Sales commissions
- $6.7M
- Placement agents
- Jefferies LLC, Cowen and Company, LLC
- First sale
- Jul 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$102MraisedJul 2020 · 17 investors · BiotechnologyRule 506(b)
- Ted YednockExecutive Officer
- Jung E. ChoiDirector
- William D. YoungDirector
- Emmett CunninghamDirector
- Thomas G. WiggansDirector
- Carol GallagherDirector
- Muneer A. SatterDirector
- Campbell MurrayDirector
- Sanjay KeswaniExecutive Officer
- Jennifer LewExecutive Officer
- Douglas LoveExecutive Officer, Director
- Ricky SunDirector
- Offering amount
- $102M
- Amount sold
- $102M
- First sale
- Jun 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$45MraisedDec 2018 · 10 investors · BiotechnologyRule 506(b)
- Campbell MurrayDirector
- Douglas LoveExecutive Officer, Director
- Thomas WiggansDirector
- Emmett CunninghamDirector
- Ricky SunDirector
- Muneer SatterDirector
- Carol GallagherDirector
- Ted YednockExecutive Officer
- William YoungDirector
- Mark L SmithExecutive Officer
- Offering amount
- $85M
- Amount sold
- $45M
- First sale
- Dec 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Annexon went on to found or lead other companies.
In the news
Frequently asked questions
- What does Annexon do?
- Annexon is a clinical-stage biopharmaceutical company developing C1q and classical complement pathway inhibitors to treat complement-mediated autoimmune, neurodegenerative, and ophthalmic disorders. Its pipeline targets diseases of the body, brain, and eye, including Guillain-Barré syndrome and geographic atrophy.
- Who founded Annexon?
- Annexon was founded by Ben Barres, Douglas Love in 2011.
- Who are Annexon's investors?
- Annexon's investors include Bain Capital Life Sciences, Correlation Ventures, New Enterprise Associates (NEA), BlackRock, Blackstone Life Sciences, Clarus Ventures, Deerfield Management Company, Janus Henderson Investors and 1 more.
- How much funding has Annexon raised?
- Annexon has disclosed $277.5M raised across 3 of its 5 known rounds.
- Where is Annexon headquartered?
- Annexon is headquartered in So. San Francisco, US.